The automated patch clamp system market has been gaining significant traction over the past few years owing to the rising prevalence of various neurological disorders such as epilepsy, Alzheimer’s disease and Parkinson’s disease. Automated patch clamp systems are used to study ion channels and receptors functions in excitable and non-excitable cells from various tissues like neurons, cardiomyocytes and others. These systems provide high-quality data at a much faster speed as compared to manual patch clamp instruments. The automated technology also mitigates variability associated with manual experiments and reduces experiment time significantly. The need for advanced diagnostic techniques and drug discovery processes have also propelled the demand for automated patch clamp systems across research institutes and pharmaceutical companies.
The Global automated patch clamp system market is estimated to be valued at US$ 579.83 Mn in 2024 and is expected to exhibit a CAGR of 6.0% over the forecast period from 2024 to 2030.
Key Takeaways
Key players operating in the Automated Patch Clamp System Market Size are GE Healthcare, Siemens Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation, Hitachi Healthcare, Canon Medical Systems Corporation, Mindray Medical International Limited, Esaote SpA, NeuroLogica Corporation, NeuroVive Pharmaceutical AG, Brainlab AG, Akili Interactive Labs Inc., Brainomix Ltd., Imaging Science International, Mevis Medical Solutions, NeuroVista, Neusoft Medical Systems, Positron Corporation, Shimadzu Corporation, Trifoil Imaging.
The key opportunities in the market include development of advanced systems with higher throughput, miniaturized systems and those integrated with novel technologies. Growing focus on neuroscience research by pharmaceutical companies as well as research institutes represent major growth opportunities.
With presence across Americas, Europe, Asia Pacific and Rest of the world, the key players are focusing on expansion in emerging markets such as Asia Pacific and Latin America through partnerships, mergers and acquisitions.
Market drivers
The major market driver is the rising cases of neurological disorders across the globe. It has propelled the demand for timely and accurate diagnosis as well as development of novel therapeutics. According to WHO, over 50 million people suffered from epilepsy, 50 million have Alzheimer's disease and 6.2 million have Parkinson's disease worldwide in 2019. With increasing geriatric population, prevalence of such disorders is expected to grow rapidly in upcoming years, augmenting the demand. Secondly, increasing R&D investments in pharmaceutical and biotechnology sector have led to rising adoption of automated patch clamp systems for drug screening and development.
PEST Analysis
Political: Government regulations regarding medical device approvals and standards compliance. Patent protection and import-export laws impact innovation and trade.
Economic: Funding availability from research grants and venture capital for early/mid-stage companies impacts technology development. Reimbursement rates determined by public and private payers affect market adoption.
Social: Growing aging population drives demand for diagnostic technologies. Increased awareness of personalized medicine empowers patients to seek advanced care options.
Technological: Advancements in automation, miniaturization, and data integration enable high-throughput screening at single-cell resolution. Cloud-based platforms support remote experimentation and collaborative research.
North America holds the largest share of the automated patch clamp system market, by value. The region's dominance can be attributed to the presence of major players, rising emphasis on drug discovery research, growing prevalence of chronic diseases, and availability of funding for life science research.
The Asia Pacific region is projected to grow at the fastest CAGR during the forecast period. Factors such as increase in healthcare expenditure, rise in the number of CROs and pharmaceutical companies, untapped opportunities in emerging countries, and growing R&D investments from government and private bodies are driving the automated patch clamp system market in the Asia Pacific region.
Get more insights on- Automated Patch Clamp System Market
